None of the 29 investors followed here reported a position in CV in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CV trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Harari Eliyahou Et AlBeneficial Owner of more than 10% of a Class of Security | Purchase at price 5.69 per share. | 1.76M | $10.00M |
| Sep 14, 2026 | Ching-Hang ShenBeneficial Owner of more than 10% of a Class of Security | Purchase at price 5.69 per share. | 878.7K | $5.00M |
| Jul 16, 2026 | Harari Eliyahou Et AlBeneficial Owner of more than 10% of a Class of Security | Purchase at price 6.73 per share. | 61.1K | $410.99K |
| Jul 7, 2026 | Harari Eliyahou Et AlBeneficial Owner of more than 10% of a Class of Security | Purchase at price 6.09 per share. | 81.3K | $495.12K |
| Jun 29, 2026 | Gouw Julia SDirector | Conversion of Exercise of derivative security at price 7.58 per share. | 2K | $15.33K |
| Jun 29, 2026 | Imperial Joanne Carol M.D.Director | Conversion of Exercise of derivative security at price 7.58 per share. | 2K | $15.33K |
| Jun 29, 2026 | Kuo Hui YingDirector | Conversion of Exercise of derivative security at price 7.58 per share. | 2K | $15.33K |
| Jun 29, 2026 | King Wen-Herng HenryDirector | Conversion of Exercise of derivative security at price 7.58 per share. | 2K | $15.33K |
| Jun 29, 2026 | Tsai Chen LungDirector | Conversion of Exercise of derivative security at price 7.58 per share. | 2K | $15.33K |
| Jun 29, 2026 | Harari MicheleDirector | Conversion of Exercise of derivative security at price 7.58 per share. | 2K | $15.33K |
| Jun 25, 2026 | Harari Eliyahou Et AlBeneficial Owner of more than 10% of a Class of Security | Purchase at price 7.35 per share. | 13.8K | $101.81K |
| Jun 7, 2026 | Imperial Joanne Carol M.D.Director | Sale at price 7.16 per share. | 1.2K | $8.59K |
| May 4, 2026 | Atkinson Douglas PatrickOfficer | Conversion of Exercise of derivative security at price 0.29 - 0.57 per share. | 107.4K | $44.69K |
| Dec 30, 2025 | Gouw Julia SDirector | Conversion of Exercise of derivative security at price 10.69 per share. | 2.9K | $30.86K |
| Dec 30, 2025 | Imperial Joanne Carol M.D.Director | Conversion of Exercise of derivative security at price 10.69 per share. | 2.9K | $30.86K |
| Dec 30, 2025 | Kuo Hui YingDirector | Conversion of Exercise of derivative security at price 10.69 per share. | 2.9K | $30.86K |
| Dec 30, 2025 | King Wen-Herng HenryDirector | Conversion of Exercise of derivative security at price 10.69 per share. | 2.9K | $30.86K |
| Dec 30, 2025 | Tsai Chen LungDirector | Conversion of Exercise of derivative security at price 10.69 per share. | 2.9K | $30.86K |
| Dec 30, 2025 | Harari MicheleDirector | Conversion of Exercise of derivative security at price 10.69 per share. | 2.9K | $30.86K |
| Aug 17, 2025 | Petersen Rebecca AnnOfficer | Conversion of Exercise of derivative security at price 0.37 per share. | 24.8K | $9.10K |
Buy / hold / sell counts
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.